330793-38-9

Basic information

• Product Name: Benzonitrile,4-bromo-2-methoxy-
• Synonyms: 4-BROMO-2-METHOXY-BENZONITRILE
• CAS NO: 330793-38-9
• Molecular Formula: C₈H₆BrNO
• Molecular Weight: 212.0433
• Product Categories: Aromatic Nitriles
• Mol File: 330793-38-9.mol
• Article Data: 16

Chemical Properties

• Boiling Point: 289.128 °C at 760 mmHg
• Flash Point: 128.66 °C
• Appearance: /
• Density: 1.563 g/cm³
• Vapor Pressure: 0.002mmHg at 25°C
• Refractive Index: 1.584
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: Benzonitrile,4-bromo-2-methoxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzonitrile,4-bromo-2-methoxy-(330793-38-9)
• EPA Substance Registry System: Benzonitrile,4-bromo-2-methoxy-(330793-38-9)

Safety Data

• Statements: 20/21/22-36/37/38
• Safety Statements: 26-36/37/39
• RIDADR: 3439
• HazardClass: 6.1
• PackingGroup: Ⅲ
• Hazardous Substances Data: 330793-38-9(Hazardous Substances Data)

Usage

Uses

4-Bromo-2-methoxybenzonitrile is a useful intermediate for organic synthesis.

InChI:InChI=1/C8H6BrNO/c1-11-8-4-7(9)3-2-6(8)5-10/h2-4H,1H3

Upstream product

• 812667-44-0 4-bromo-2-methoxybenzamide 
• 67-56-1 methanol 
• 105942-08-3 4-bromo-6-fluorobenzonitrile 
• 124-41-4 sodium methylate 
• 865-33-8 potassium methanolate 
• 623-00-7 4-bromobenzenecarbonitrile 
• 5213-16-1 4-bromo-2-methoxybenzoyl chloride 
• 72135-36-5 4-bromo-2-methoxybenzoic acid 
• 141-52-6 sodium ethanolate 

Downstream Products

• 812667-45-1 4-bromo-2-methoxybenzamidine hydrochloride 
• 288067-35-6 4-bromo-2-hydroxy-benzonitrile 
• 677777-45-6 4-cyano-3-methoxyphenylboronic acid 
• 72135-36-5 4-bromo-2-methoxybenzoic acid 
• 43192-33-2 4-bromo-2-methoxybenzaldehyde 
• 1018326-11-8 4-(4-(2-(4-chloro-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetyl)piperidin-1-yl)-2-methoxybenzonitrile 
• 1166831-57-7 tert-butyl 3-(4-cyano-3-methoxyphenyl)acrylate 
• 1100508-57-3 2-methoxy-4-([1-(([(4S)-4-methyl-2,5-dioxoimidazolidin-4-yl]methyl)sulfonyl)-1,2,3,6-tetrahydropyridin-4-yl]ethynyl)benzonitrile 
• 812667-44-0 4-bromo-2-methoxybenzamide 
• 1255207-18-1 2-(methyloxy)-4-prop-2-en-1-ylbenzonitrile 
• 755030-94-5 2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile 
• 1255870-59-7 4-(5-formyl-pyridin-3-yl)-2-methoxy-benzonitrile 
• 1260507-41-2 C₁₉H₁₇N₃O₃ 
• 1308669-00-2 2-methoxy-4-[5-fluoro-4-(1-hydroxy-ethyl)-pyridin-3-yl]-benzonitrile 

Relevant articles and documents

NOVEL UREAS HAVING ANDROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF

The present disclosure relates to novel compounds, pharmaceutical compositions containing such compounds, and their use in prevention and treatment of cancer and related diseases and conditions. In some embodiments, the compounds disclosed herein exhibit

TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF

The present invention is directed to substituted indole compounds of formula (I) which are tropomyosin-related kinase (Trk) family protein kinase inhibitors, and hence are useful in the treatment of pain, inflammation, cancer, restenosis, atherosclerosis, psoriasis, thrombosis, adisease, disorder, injury, or malfunction relating to dysmyelination or demyelination or a disease or disorder associated with abnormal activities of nerve growth factor (NGF) receptor TrkA.

4, 5-DIHYDRO-LH-PYRAZOLE COMPOUNDS AND THEIR PHARMACEUTICAL USES

Mineralocorticoid receptor antagonists (MRa), pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat, for example, diabetic nephropathy and hypertension in mammals, including humans.